I am still very on the fence on this since the Adcom. I hope we all make money when the decision arrives
MarkyBoy212
предходната седмица
A new buy rating and 2 maintained buys very nice
A new buy rating and 2 maintained buys very nice, hoping this gets approval after earnings and award
ByronKS
предходната седмица
Capricor earnings report
See the Capricor Therapeutics earnings report below. Good luck! 🤞🏼🍀
https://web.quartr.com/link/companies/5913/events/732825/report?rp=0&documentId=4012432
MarkyBoy212
преди 2 седмици
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
TerraNova23
преди 2 седмици
Anyone else think this will fail?
According to Adam Feuerstein, Capricor faces two major risks:
Weak Clinical Evidence: The FDA may consider Deramiocel's efficacy data insufficient for approval.
Public Pressure on the FDA: Capricor's public statements could suggest concerns about its chances of approval.
And there is still the 3-9 vote from before.
Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
Prayers
преди 3 месеца
This too (and yh I DO wish I did this in CFD lol)
GGGGM
преди 3 месеца
Thank God for this stock today
$CAPR to the rescue, thank you thus far... NFA
kosen
преди 3 месеца
This pattern looks exactly like yesterday.
If it completely duplicates yesterday’s pattern, we see 11.5 Today???
kosen
преди 3 месеца
What do we think
At a loss now, watching a bit
GGGGM
преди 3 месеца
We going up.. The News is here.. NFA.
$CAPR would soar today as the long awaited news is finally here.
The FDA accepted a major amendment to Capricor's Biologics License Application (BLA) containing 24-month Phase 3 HOPE-3 extension data. Instead of issuing an immediate rejection, the FDA extended the PDUFA target action date to November 22, 2026.
I got in early at $8 and waiting to see above 11 and above..
Note that THIS IS NOT A FINANCIAL ADVICE... NFA
SKM2086
преди 3 месеца
PT - $54
I'm going with a conservative $25-30. We're on the right track now. Definitely close to making permanent moves upwards.
https://uk.investing.com/news/stock-market-news/oppenheimer-upgrades-capricor-stock-rating-on-regulatory-update-93CH-4846076
MarkyBoy212
преди 3 месеца
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA nice news guys
Hazlaw1234
преди 3 месеца
$CAPR feels like one to watch very closely today 👀
The official PDUFA target date is tomorrow, Saturday 22 August, but with that falling on a weekend there’s a very real possibility we hear something from the FDA today instead.
As of now there’s been no decision announced, so I’d expect a lot of eyes on CAPR once the US session gets going and especially into after hours.
Could be a very important day for the stock. Definitely worth keeping notifications on.
NFA
На тази страница може да видиш съдържание, генерирано от клиентите, за което Trading 212 не носи отговорност. Винаги прави собствени проучвания. Trading 212 предоставя единствено услуга за изпълнение и не предлага инвестиционен съвет или управление на портфолиото.
Инвестирай в готови пайове или създай свой собствен, като избираш от хиляди акции и ETF-и
Научи повече
Научи повече
Гледай видеото
Така можеш да притежаваш дял дори от най-скъпите акции като Google, Amazon и Apple
Гледай видеото
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lisbon
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lisbon
Виж всички инструменти за търговия
Поддръжка 24/7
Отговаряме в чата средно за 29 секунди
Започни да търгуваш сега
Присъедини се към над 5 милиона потребители
Изтегли приложението
Отвори сметка
Инсталирай мобилното приложение
Стойностите са глобални. Броят клиенти включва само тези със захранени сметки.
Отлично
Оценка 4,6/5 въз основа на 108 764 отзива в
Trustpilot
Оценка 4,6/5 въз основа на 108 764 отзива в
Trustpilot
Поканен
Great app very easy to use and lots of…
Great app very easy to use and lots of information. Always upto date with balances and share prices etc.
Поканен
Smooth experience
The whole thing is smooth and seamless and makes things easy overall.
Поканен
Really easy to use
Really easy to use. Secure and has the best functionality and features.
Поканен
Easy to keep up with as informed…
Easy to keep up with as informed everyday or week on interest made . Easy to set up account . No problems .
Поканен
Easy to operate and work with
Easy to operate and work with. Works very fast and accurately.
Поканен
How you rate the app
This app is so easy to use and safe really love it.
Поканен
I opened a cash ISA with them
I opened a cash ISA with them. It was really straightforward to do and interest is added daily. Nice ,easy to use app as well.
Поканен
Easy to navigate makes investing…
Easy to navigate makes investing interesting, transferred my investments from HL which was very straightforward and now not paying dealing fee’s
Very Happy
Поканен
App is easy to work
App is easy to work
Good interest rate
Daily interest updates
Поканен
Very good and informative always stay…
Very good and informative always stay on track with your investments
Поканен
Reliable
Reliable, trustworthy app to store your money and to build on your existing wealth if you are financially sensible and smart.
Поканен
Great app
Great app. I would recommend to anyone that’s into investing and making their money grow .
Поканен
Very easy app to register and use
Very easy app to register and use! Really pleased.
Поканен
Clear app
Clear app. Easy to invest. Took a whike for money to get in because i did it from bank rather than in app
Поканен
Very smooth and user friendly
Very smooth and user friendly. Have had zero issues having moved from other brokerages. Will keep using.
Поканен
Easy to set up and to regular monitor…
Easy to set up and to regular monitor how its performing.
Поканен
Competitive rates and quick transfers
Very good on money transfers in and out. They take place immediately unlike some other providers.
Very competitive rate on Cash ISA
Поканен
Customer support is quick and…
Customer support is quick and effective. The app is well organised and easy to use. Would reccommend for anyone even complete beginners.
Поканен
Easy to set up the Cash ISA
Easy to set up the Cash ISA, funds arrived in account almost immediately. Great to see interest accrual amounts daily.
Поканен
Reliable
Reliable, Secure. Using it for past 3 years
Някои от положителните клиентски отзиви
Нашите награди
Често задавани въпроси
Каква е цената на акциите на Capricor Therapeutics?
Текущата цена на Capricor Therapeutics е 7,59 $.
Какъв е 52-седмичният максимум на Capricor Therapeutics?
52-седмичният максимум за Capricor Therapeutics е 40,37 $.
Какъв е 52-седмичният минимум на Capricor Therapeutics?
52-седмичният минимум за Capricor Therapeutics е 2,96 $.
Каква е седмичната ефективност на Capricor Therapeutics?
През изминалата седмица цената на Capricor Therapeutics се е променила с -20,36%.
Какво е месечната ефективност на Capricor Therapeutics?
През изминалия месец цената на Capricor Therapeutics се е променила с 14,14%.
Каква е 3-месечната ефективност на Capricor Therapeutics?
През последните три месеца цената на Capricor Therapeutics се е променила с -4,89%.
Каква е 6-месечната ефективност на Capricor Therapeutics?
През последните шест месеца цената на Capricor Therapeutics се е променила с -71,81%.
Каква е годишната ефективност на Capricor Therapeutics?
През изминалата година цената на Capricor Therapeutics се е променила с 31,54%.